Title: The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer
Authors: van Elmpt, Wouter ×
De Ruysscher, Dirk
van der Salm, Anke
Lakeman, Annemarie
van der Stoep, Judith
Emans, Daisy
Damen, Eugène
Ollers, Michel
Sonke, Jan-Jakob
Belderbos, José #
Issue Date: Jul-2012
Publisher: Elsevier Science Publishers
Series Title: Radiotherapy and Oncology vol:104 issue:1 pages:67-71
Abstract: The local site of relapse in non-small cell lung cancer (NSCLC) is primarily located in the high FDG uptake region of the primary tumour prior to treatment. A phase II PET-boost trial (NCT01024829) randomises patients between dose-escalation of the entire primary tumour (arm A) or to the high FDG uptake region inside the primary tumour (>50% SUV(max)) (arm B), whilst giving 66Gy in 24 fractions to involved lymph nodes. We analysed the planning results of the first 20 patients for which both arms A and B were planned.
ISSN: 0167-8140
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Non-KU Leuven Association publications
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science